Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver

Transplantation. 2014 Sep 15;98(5):e43-5. doi: 10.1097/TP.0000000000000303.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Cell-Free System
  • DNA / blood*
  • Female
  • Graft Rejection / blood
  • Graft Rejection / diagnosis*
  • HELLP Syndrome*
  • Humans
  • Liver Transplantation*
  • Middle Aged
  • Pregnancy
  • Tissue Donors*

Substances

  • Biomarkers
  • DNA